Princeton, NJ, US.
The Director (WW HEOR HQ, Cardiovascular) will lead HEOR strategy for multiple indications of milvexian program. Milvexian is an investigational agent intended to address several indications in the thrombosis disease landscape. This asset is currently in Phase 2 with expected data results in 1H 2022. Milvexian is projected to be a multi-billion-dollar product and considered critical asset for BMS’ expanding Cardiovascular portfolio. Bristol Myers Squibb entered a collaboration with Janssen pharmaceuticals in 2018 to co-develop and co-commercialize milvexian. Both companies, as an alliance are collaborating to complete Phase 2, prepare for Phase 3 and strategically plan for commercialization success in the future.
The Director will serve as the strategic and scientific lead for all HEOR activities (real world evidence generation, economic modeling, patient-reported outcomes assessment) for multiple milvexian indications. The Director will be responsible for development of value evidence generation strategy to optimize the preparation of HEOR evidence required for future regulatory and HTA submissions. The Director will also partner closely with access, R&D, commercialization, and medical organizations to ensure HEOR insights are incorporated in the planning and execution of Phase 3 development program to drive value differentiation.
- Lead global health economic and outcomes research in cardiovascular therapeutic area
- Develop and execute innovative WWHEOR plans including real world evidence generation, economic modeling, and patient-reported outcomes assessment
- Identify opportunities and lead studies to differentiate and enhance value propositions of BMS assets
- Direct efforts to support market access activities
- Build relationships with key BMS groups to maximize opportunities
- Maintain and develop strong relationships and visibility with external key opinion leaders in medicine, health economics, and outcomes research
- Advanced degree (such as MS, MPH, Pharm D, MD or PhD) preferably in a quantitative discipline such as epidemiology, health economics or health services research
- At least five years of experience conducting outcomes research, health economics research, health services research, health technology assessment or conducting epidemiologic studies
- The candidate should have demonstrated scientific leadership, evidenced by peer-reviewed publications based on real world data studies, economic modeling, and patient-reported outcomes assessment
- The candidate should be capable of distilling the essential elements of complex issues for senior internal and external stakeholders
- The candidate should have successful experience operating in a highly matrixed organization
At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Physical presence at the BMS worksite or physical presence in the field is an essential job function of this role which the Company deems critical to collaboration, innovation, productivity, employee well-being and engagement, and enhances the Company culture.
To protect the safety of our workforce, customers, patients and communities, the policy of the Company requires all employees and workers in the U.S. and Puerto Rico to be fully vaccinated against COVID-19, unless they have received an exception based on an approved request for a medical or religious reasonable accommodation. Therefore, all BMS applicants seeking a role located in the U.S. and Puerto Rico must confirm that they have already received or are willing to receive the full COVID-19 vaccination by their start date as a qualification of the role and condition of employment. This requirement is subject to state and local law restrictions and may not be applicable to employees working in certain jurisdictions such as Montana. This requirement is also subject to discussions with collective bargaining representatives in the U.S.
Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or if you are applying to a role based in the U.S. or Puerto Rico and you believe that you are unable to receive a COVID-19 vaccine due to a medical condition or sincerely held religious belief, during or any part of the recruitment process, please direct your inquiries to our career center.
Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.
This job is posted by Bristol-Myers Squibb.
This link brings you to the website of Bristol-Myers Squibb.
When you apply, please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!